Accuracy and Predictive Features of FDG-PET/CT and CT for Diagnosis of Lymph Node Metastasis of T1 Non-small-cell Lung Cancer Manifesting As a Subsolid Nodule

Overview

Journal Eur Radiol

Specialty Radiology

Date 2012 Feb 24

PMID 22358427

Citations 21

Authors

Sang Min Lee

Chang Min Park

Jin Chul Paeng

Hyung Jun Im

Jin Mo Goo

Hyun-Ju Lee

Chang Hyun Kang

Young Whan Kim

Jung Im Kim

Affiliations

Soon will be listed here.

Abstract

Objectives: To retrospectively evaluate the diagnostic accuracy and predictive features of F-18 fluorodeoxyglucose positron emission tomography/ computed tomography (FDG-PET/CT) and CT in lymph node (LN) staging of T1 non-small-cell lung cancers (NSCLCs) manifesting as subsolid nodules.

Methods: From January 2005 to May 2011, 160 patients with pathologically proven T1 subsolid NSCLCs with LN staging were included in this study. Diagnostic accuracies of FDG-PET/CT and CT for LN staging were evaluated. Maximum standardised uptake value (SUVmax) and CT features of primary tumours were evaluated to investigate predictive factors for LN metastasis.

Results: LN metastases were found in nine of the 160 patients (5.6%). No LN metastasis was present in patients with a solid proportion ≤50%. Sensitivity, specificity and accuracy of FDG-PET/CT for LN staging on a per-patient basis were 11.1%, 86.1% and 81.9%; those of CT were 11.1%, 96.7% and 91.9%. Among patients with a solid proportion >50%, there were significant differences in SUVmax, solid portion size, solid proportion and lesion location between patients with and without LN metastasis. Multivariate analysis revealed that higher SUVmax, a larger solid proportion and central location were independent predictors of LN metastasis.

Conclusions: FDG-PET/CT adds little value to CT in the lymph node staging of T1 subsolid NSCLCs.

Key Points: Lymph node (LN) metastases are important in non-small-cell lung cancer (NSCLC). • Positron emission tomography (PET) helps to stage solid NSCLCs. • FDG-PET/CT adds little to the LN staging of T1 subsolid NSCLCs. • No LN metastasis in patients with a solid proportion ≤50%. • LN metastasis is more common in solid and/or centrally sited tumours.

Citing Articles

Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer?.

Imai K, Kurihara N, Konno M, Mori N, Takashima S, Kuriyama S Cancer Imaging. 2024; 24(1):69.

PMID: 38831467 PMC: 11149246. DOI: 10.1186/s40644-024-00714-7.

Standardized uptake value of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma.

Jin B, Wen X, Tian H, Guo H, Hao M, Wu J Cancer Med. 2024; 13(7):e6961.

PMID: 38549459 PMC: 10979183. DOI: 10.1002/cam4.6961.

Computer-aided diagnosis of distal metastasis in non-small cell lung cancer by low-dose CT based radiomics and deep learning signatures.

Song X, Duan X, He X, Wang Y, Li K, Deng B Radiol Med. 2024; 129(2):239-251.

PMID: 38214839 DOI: 10.1007/s11547-024-01770-6.

Prognostic impact of highly solid component in early-stage solid lung adenocarcinoma.

Kato T, Iwano S, Hanamatsu Y, Nakaguro M, Emoto R, Okado S Quant Imaging Med Surg. 2023; 13(9):5641-5652.

PMID: 37711790 PMC: 10498257. DOI: 10.21037/qims-23-36.

Impact of ground glass opacity in a three-dimensional analysis for pathological findings and prognosis in stage IA pure solid lung cancer.

Tsuchida H, Tanahashi M, Suzuki E, Yoshii N, Watanabe T, Yobita S J Thorac Dis. 2023; 15(7):3829-3839.

PMID: 37559660 PMC: 10407529. DOI: 10.21037/jtd-23-341.

References

Kim H, Shim Y, Lee K, Han J, Yi C, Kim Y . Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007; 245(1):267-75. DOI: 10.1148/radiol.2451061682. View

Aoki T, Nakata H, Watanabe H, Nakamura K, Kasai T, Hashimoto H . Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol. 2000; 174(3):763-8. DOI: 10.2214/ajr.174.3.1740763. View

Lee H, Goo J, Lee C, Yoo C, Kim Y, Im J . Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results. Korean J Radiol. 2007; 8(1):22-31. PMC: 2626694. DOI: 10.3348/kjr.2007.8.1.22. View

Yi C, Lee K, Kim B, Shim S, Chung M, Sung Y . Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer. AJR Am J Roentgenol. 2007; 188(2):318-25. DOI: 10.2214/AJR.05.2081. View

Nakata M, Saeki H, Takata I, Segawa Y, Mogami H, Mandai K . Focal ground-glass opacity detected by low-dose helical CT. Chest. 2002; 121(5):1464-7. DOI: 10.1378/chest.121.5.1464. View

. CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. Radiology. 2007; 243(1):239-49. DOI: 10.1148/radiol.2431060467. View

Detterbeck F, Boffa D, Tanoue L . The new lung cancer staging system. Chest. 2009; 136(1):260-271. DOI: 10.1378/chest.08-0978. View

Chou H, Chang T, Yen T, Ng K, Hsueh S, Ma S . Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol. 2005; 24(1):123-8. DOI: 10.1200/JCO.2005.03.5964. View

Henschke C, Yankelevitz D, Mirtcheva R, McGuinness G, McCauley D, Miettinen O . CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol. 2002; 178(5):1053-7. DOI: 10.2214/ajr.178.5.1781053. View

10.

Aoki T, Tomoda Y, Watanabe H, Nakata H, Kasai T, Hashimoto H . Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology. 2001; 220(3):803-9. DOI: 10.1148/radiol.2203001701. View

11.

Lee J, Kim B, Lee D, Chung J, Lee M, Kim S . 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging. 2009; 36(11):1794-802. DOI: 10.1007/s00259-009-1155-4. View

12.

Mountain C, Dresler C . Regional lymph node classification for lung cancer staging. Chest. 1997; 111(6):1718-23. DOI: 10.1378/chest.111.6.1718. View

13.

Tahara R, Lackner R, Graver L . Is there a role for routine mediastinoscopy in patients with peripheral T1 lung cancers?. Am J Surg. 2001; 180(6):488-91; discussion 491-2. DOI: 10.1016/s0002-9610(00)00509-2. View

14.

Lardinois D, Weder W, Hany T, Kamel E, Korom S, Seifert B . Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003; 348(25):2500-7. DOI: 10.1056/NEJMoa022136. View

15.

Hasegawa M, Sone S, Takashima S, Li F, Yang Z, Maruyama Y . Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2001; 73(876):1252-9. DOI: 10.1259/bjr.73.876.11205667. View

16.

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K . Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. 2004; 45(1):19-27. DOI: 10.1016/j.lungcan.2004.01.009. View

17.

Goo J, Park C, Lee H . Ground-glass nodules on chest CT as imaging biomarkers in the management of lung adenocarcinoma. AJR Am J Roentgenol. 2011; 196(3):533-43. DOI: 10.2214/AJR.10.5813. View

18.

Kim Y, Lee K, Kim B, Choi J, Kim H, Kwon O . Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer. 2007; 109(6):1068-77. DOI: 10.1002/cncr.22518. View

19.

Choi Y, Shim Y, Kim J, Kim K . Mediastinoscopy in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2003; 75(2):364-6. DOI: 10.1016/s0003-4975(02)04411-9. View

20.

Park C, Goo J, Lee H, Lee C, Chun E, Im J . Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. Radiographics. 2007; 27(2):391-408. DOI: 10.1148/rg.272065061. View